Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion type Assertion NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_head.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion description "[Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_provenance.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion evidence source_evidence_literature NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_provenance.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion SIO_000772 17189407 NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_provenance.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion wasDerivedFrom befree-20150227 NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_provenance.
- NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_assertion wasGeneratedBy ECO_0000203 NP861933.RAGb3AjQdOAKzIgUmdi7vxDHBKHATp4N1GA-l0QMd3s00130_provenance.